LIPOPROTEIN - ANVISA Registration 80158990198

Access comprehensive regulatory information for LIPOPROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80158990198 and manufactured by RANDOX LABORATORIES LTD.. The registration is held by RANDOX BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIASYS DIAGNOSTIC SYSTEMS GMBH, SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80158990198
Registration Details
ANVISA Registration Number: 80158990198
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Lp(a)
Risk Class II

Registration Details

80158990198

25351362644201498

05257628000190

Company Information

Northern Ireland (United Kingdom)
PT: IRLANDA DO NORTE (REINO UNIDO)

Dates and Status

Dec 01, 2014

VIGENTE

09/18/2025 19:00:01